Finance Home - My Yahoo - Yahoo! - Help

Tuesday, December 22, 2009, 1:18PM ET - U.S. Markets close in 2 hours and 42 minutes. Dow  0.51% Nasdaq  0.61%

Idenix Pharmaceuticals Inc. (IDIX)

At 12:57PM ET: 2.14   0.04 (1.90%)

MORE ON IDIX

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Wed, Nov 4, 2009 • IDENIX PHARMACEUTICALS INC Financials EDGAR Online Financials (Wed, Nov 4) Tue, Nov 3, 2009 • Idenix Pharmaceuticals Initiates Phase II Clinical Trial of IDX184 in Combination With Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Virus (HCV) PR Newswire (Tue, Nov 3) Fri, Oct 30, 2009 • Movers roundup: Novatel Wireless, Harman AP (Fri, Oct 30) • Idenix down; Novartis won't license drug candidate AP (Fri, Oct 30) • Idenix Pharma downgraded by Caris & Company Briefing.com (Fri, Oct 30) • YRC Worldwide, AXT: Early Volume Plays at TheStreet.com (Fri, Oct 30) • Idenix 3Q loss narrows as costs fall, revenue up AP (Fri, Oct 30) • Novartis not licensing Idenix's hepatitis C drug AP (Fri, Oct 30) • Idenix Pharmaceuticals Presents Data on IDX184 for the Treatment of Hepatitis C Virus (HCV) PR Newswire (Fri, Oct 30) Thu, Oct 29, 2009 • Idenix Pharmaceuticals, Inc. Earnings Call scheduled for 4:30 pm ET today CCBN (Thu, Oct 29) • IDENIX PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online (Thu, Oct 29) • Idenix Retains Worldwide Rights to Develop and Commercialize IDX184 for the Treatment of HCV PR Newswire (Thu, Oct 29) • Idenix Pharmaceuticals Reports Third Quarter and Nine Month 2009 Financial Results PR Newswire (Thu, Oct 29) • Q3 2009 Idenix Pharmaceuticals, Inc. Earnings Release - After Market Close CCBN (Thu, Oct 29) Tue, Oct 27, 2009 • Idenix Pharmaceuticals to Present at the Oppenheimer 20th Annual Healthcare Conference PR Newswire (Tue, Oct 27) Thu, Oct 22, 2009 • Idenix to Host Conference Call Discussing Third Quarter 2009 Financial Results PR Newswire (Thu, Oct 22) Thu, Oct 1, 2009 • Idenix Announces Data Presentations at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) PR Newswire (Thu, Oct 1) Mon, Sep 28, 2009 • Idenix Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference PR Newswire (Mon, Sep 28) Thu, Sep 17, 2009 • [video] Best $5 Stocks at TheStreet.com (Thu, Sep 17) Wed, Aug 5, 2009 • IDENIX PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online (Wed, Aug 5) Older Headlines - Download Recent Headlines View headlines from: Wed, Aug 5, 2009Wed, Jul 29, 2009Wed, Jul 22, 2009Wed, Jul 15, 2009Wed, Jul 8, 2009Wed, Jul 1, 2009Wed, Jun 24, 2009Wed, Jun 17, 2009Wed, Jun 10, 2009Wed, Jun 3, 2009 Add IDIX News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage